Synthesis and pharmacology of a new potential anti-inflammatory drug, 1-(3',4'-methylenedioxybenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid (ID-955).
D000085:Acetates / Q000037:antagonists & inhibitors; D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D001798:Blood Proteins; D002199:Capillary Permeability / Q000187:drug effects; D002351:Carrageenan / Q000037:antagonists & inhibitors; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control*; D004890:Erythema / Q000517:prevention & control*; D005122:Exudates and Transudates / Q000187:drug effects; D005334:Fever / Q000188:drug therapy; D003368:Gossypium; D006099:Granuloma / Q000517:prevention & control*; D006168:Guinea Pigs; D007106:Immune Sera / Q000037:antagonists & inhibitors; D007210:Indoleacetic Acids / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D010538:Peritonitis / Q000517:prevention & control*; D011489:Protein Denaturation / Q000187:drug effects; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D051381:Rats; D014466:Ultraviolet Rays
D000085:Acetates; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D007106:Immune Sera; D007210:Indoleacetic Acids; D011837:Radiation-Protective Agents; D002351:Carrageenan; D010113:Oxyphenbutazone; D007213:Indomethacin